Glimfirst MV 2 Tablet ER
Marketer
Sinsan Pharmaceuticals
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimfirst MV 2 Tablet ER
Diabetace MV 2 Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer Diabetace MV 2 ER with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.
Primary Ingredients of Glimfirst MV 2 Tablet ER
No text provided to rephrase.
Uses of Glimfirst MV 2 Tablet ER
Managing type 2 diabetes
Major Benefits of Glimfirst MV 2 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimfirst MV 2 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Glimfirst MV 2 Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimfirst MV 2 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimfirst MV 2 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet on an empty stomach.
How Glimfirst MV 2 Tablet ER works:
Glimfirst MV 2 Extended-Release tablets contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimfirst MV 2 Tablet ER and alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Glimfirst MV 2 Tablet ER during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimfirst MV 2 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Glimfirst MV 2 Tablet ER is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is necessary. Furthermore, this medication is not advised for patients experiencing severe kidney disease.
LiverCAUTION
Exercise caution when prescribing Glimfirst MV 2 Tablet ER to individuals with hepatic impairment. Dosage modification of Glimfirst MV 2 Tablet ER may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, Glimfirst MV 2 Tablet ER should typically commence at a reduced dosage; its use is contraindicated in those with severe liver disease.
What if you forget to take Glimfirst MV 2 Tablet ER :
Should you forget to take a Glimfirst MV 2 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimfirst MV 2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |


